|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Revenue | |||
| Cost of sales | |||
| Gross profit | |||
| Goodwill impairment | |||
| Gain (loss) on foreign exchange | |||
| General and administrative expenses | |||
| Operating loss | |||
| Interest income | |||
| Gain on remeasurement of contingent consideration | |||
| Fair value gains on embedded derivatives | |||
| Fair value loss on warrants | |||
| Gain (loss) on remeasurement of deferred consideration | |||
| Interest expense | |||
| Loss before tax | |||
| Income tax | |||
| Loss for the year | |||
| Exchange gain (loss) on translation of foreign operations | |||
| Total other comprehensive gain (loss) income for the year | |||
| Total comprehensive loss for the year | |||
| Net loss per ordinary share: | |||
| Basic net loss per ordinary share (in dollars per share) | |||
| Diluted net loss per ordinary share (in dollars per share) | |||
| Net loss for the year: | |||
| Attributable to ordinary shareholders of Lifezone | |||
| Attributable to non-controlling interests | |||
| Total comprehensive loss for the year: | |||
| Attributable to ordinary shareholders of Lifezone | |||
| Attributable to non-controlling interests |
Loading...
